ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
17.953,15
0,17%
S&P 500
5.018,39
-0,34%
Dow Jones
37.903,29
0,00%
Euro vs US Dollar
1,06981
-0,18%
Bitcoin
58.317,86
0,14%
Registration Strip Icon for charts Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. AMEX
  6. Cel Sci Corporation New (CVM)

  7. Cel Sci Corporation New (CVM) News

CVM Cel Sci Corporation New

1,42
0,00 (0,00%)
Vor Marktöffnung
Zuletzt aktualisiert: 13:11:16
Verzögert um 15 Minuten
Name Symbol Markt Aktientyp
Cel Sci Corporation New CVM AMEX Common Stock
  Änderung Änderung % Aktuell Zeit
Upgrade Icon
0,00 0,00% 1,42 13:11:16
Handelsbeginn Niedrig Hoch Schlusskurs Handelsende
1,42
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
23.4.202415:00BWCEL-SCI Appoints Mario Gobbo to Its Board of Directors
19.3.202414:00BWCEL-SCI’s LEAPS Vaccine Offers Promising New Paradigm to..
07.3.202417:33EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
07.3.202417:33EDGAR2Form ARS - Annual Report to Security Holders
06.3.202414:45BWCEL-SCI Corporation Issues Letter to Shareholders
15.2.202414:00BWCEL-SCI Corporation Reports First Quarter Fiscal 2024..
14.2.202422:31EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
13.2.202418:00BWCEL-SCI Announces Closing of $7.75 Million Public Offering..
09.2.202414:30BWCEL-SCI Announces Pricing of $7.75 Million Public Offering..
06.2.202415:00BWCEL-SCI Completes Commissioning of Its Multikine..
31.1.202415:00BWEuropean Medicines Agency Grants CEL-SCI a Waiver of Strict..
02.1.202415:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02.1.202415:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02.1.202415:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22.12.202322:01EDGAR2Form S-8 - Securities to be offered to employees in employee..
22.12.202314:00BWCEL-SCI Reports Fiscal 2023 Financial Results and Clinical &..
21.12.202322:15EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
04.12.202314:30BWUK’S National Institute for Health and Care Excellence..
20.11.202323:25EDGAR2Form 8-K - Current report
20.11.202322:15BWCEL-SCI Announces Closing of $5 Million Public Offering of..
16.11.202314:30BWCEL-SCI Announces Pricing of $5 Million Offering of Common..
30.10.202322:01EDGAR2Form 8-K - Current report
30.10.202314:20BWCEL-SCI Issues Letter to Shareholders
24.10.202316:18EDGAR2Form 8-K - Current report
24.10.202314:00BWCEL-SCI Releases Video Detailing Recent Phase 3 Findings &..
23.10.202315:15BW5-Year Head & Neck Cancer Survival Increased From 45% to 73%..
19.10.202314:00BWCEL-SCI Readies Its Multikine Manufacturing Facility for..
05.10.202314:45BWCEL-SCI Files Request With the UK’s MHRA Regarding Path to..
03.10.202316:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03.10.202316:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03.10.202316:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26.9.202315:00BWCEL-SCI Submits Scientific Advice Filing to European..
31.8.202323:16EDGAR2Form 8-K - Current report
11.8.202314:00BWCEL-SCI Corporation Reports Third Quarter Fiscal 2023..
10.8.202322:53EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10.8.202322:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10.8.202322:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10.8.202322:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10.8.202322:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10.8.202322:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10.8.202322:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10.8.202322:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10.8.202322:10EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
20.7.202322:10EDGAR2Form 8-K - Current report
20.7.202317:36BWCEL-SCI Announces Closing of Public Offering
18.7.202322:05EDGAR2Form 8-K - Current report
18.7.202303:23BWCEL-SCI Announces Pricing of Public Offering
17.7.202322:05BWCEL-SCI Announces Proposed Public Offering of Common Stock
14.7.202318:25EDGAR2Form 8-K - Current report
14.7.202315:15BWCEL-SCI Concludes Positive Meeting With U.S. FDA Concerning..

Kürzlich von Ihnen besucht

AMEX
CVM
Cel Sci
Delayed Upgrade Clock
ADVFN Logo

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten